Torrent Pharmaceuticals Ltd represents values of excellence, integrity, and commitment in the pharmaceutical industry. As one of the largest pharmaceutical companies in India, Torrent Pharmaceuticals is dedicated to providing high-quality and affordable healthcare solutions to patients worldwide. The company's corporate philosophy revolves around innovation, ethical practices, and customer-centricity, ensuring the delivery of safe and effective medicines. With a strong emphasis on research and development, Torrent Pharmaceuticals strives to contribute to the well-being of society by constantly expanding its product portfolio and enhancing healthcare access.

Torrent Pharmaceuticals Ltd is primarily present in multiple countries and regions. The company has a strong global presence and operates in several key markets such as India, the United States, Brazil, Germany, Spain, Russia, and many more. With its diverse geographic footprint, Torrent Pharmaceuticals Ltd has established a wide customer base and significant market reach. The company's global expansion helps facilitate access to its products and allows it to cater to the healthcare needs of various populations around the world.

Torrent Pharmaceuticals Ltd has achieved several significant milestones in its journey. The company has successfully expanded its global presence, entering new markets and launching various products. It has received multiple regulatory approvals for its quality-driven manufacturing facilities, ensuring compliance with international standards. Torrent Pharmaceuticals Ltd has been recognized for its commitment to research and development, developing innovative healthcare solutions and improving patient outcomes. The company has also demonstrated strong financial performance, consistently delivering sustainable growth and creating value for its stakeholders. With its dedication to excellence and continuous improvement, Torrent Pharmaceuticals Ltd continues to make remarkable strides in the pharmaceutical industry.

Torrent Pharmaceuticals Ltd is a reputed pharmaceutical company with a rich history and background. Established in 1959, Torrent Pharmaceuticals has emerged as one of India's leading pharmaceutical companies. With a diverse product portfolio spanning therapeutic areas like cardiovascular, central nervous system, and gastroenterology, the company has made significant contributions to healthcare. Torrent Pharmaceuticals is committed to quality, innovation, and patient-centricity, driving its growth within India and globally. Over the years, the company has garnered recognition for its research and development capabilities, extensive manufacturing infrastructure, and strong ethical practices, making it a trusted player in the pharmaceutical industry.

Torrent Pharmaceuticals Ltd has several main competitors in the market. Some of the prominent competitors of Torrent Pharmaceuticals Ltd include Sun Pharmaceutical Industries Ltd, Lupin Limited, Cipla Ltd, Dr. Reddy's Laboratories Ltd, and Aurobindo Pharma Ltd. These companies operate in the same industry and offer similar products and services, leading to competition in the market. However, with its strong market presence and diverse product portfolio, Torrent Pharmaceuticals Ltd continues to strive and maintain its position among the top competitors.

Torrent Pharmaceuticals Ltd is primarily active in the pharmaceutical industry.

The business model of Torrent Pharmaceuticals Ltd involves the research, development, production, and marketing of high-quality generic pharmaceuticals and active pharmaceutical ingredients (APIs). As one of the leading players in the Indian pharmaceutical industry, Torrent Pharmaceuticals focuses on delivering affordable and accessible healthcare solutions to a wide range of patients. Their business strategy entails a strong emphasis on product quality, regulatory compliance, and timely introduction of new products. Torrent Pharmaceuticals aims to address various therapeutic segments, including cardiology, diabetology, gastroenterology, and pain management, through a robust portfolio of formulations. The company strives to enhance its global footprint and maintain a strong market position through continuous innovation and strategic partnerships.

Torrent Pharmaceuticals의 P/E 비율은 63.39입니다.

Torrent Pharmaceuticals의 P/S 비율은 9.79입니다.

Torrent Pharmaceuticals에 대한 AlleAktien 품질 점수는 9/10입니다.

Torrent Pharmaceuticals 매출은 107.28 조. INR입니다.

Torrent Pharmaceuticals 이익은 16.56 조. INR입니다.

Torrent Pharmaceuticals Ltd is an Indian pharmaceutical company founded in 1959. It focuses on the manufacturing and distribution of pharmaceuticals and operates in various areas including generics, over-the-counter products, active pharmaceutical ingredients, and bio-pharmacology. The company is known for its cost-effective alternatives to branded drugs and has a strong presence in the Indian and global markets. It specializes in generics, over-the-counter products, active pharmaceutical ingredients, and bio-pharmacology. It has a wide range of products in its portfolio, including anti-infectives, cardiovascular drugs, CNS drugs, gastrointestinal drugs, painkillers, and OTC products. Torrent Pharmaceuticals has a reputation as a leading generic manufacturer in India.

Torrent Pharmaceuticals은(는) 연간 번의 배당을 통해 16.5 INR의 배당금을 지급합니다.

Torrent Pharmaceuticals의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Torrent Pharmaceuticals의 ISIN은 INE685A01028입니다.

Torrent Pharmaceuticals의 티커는 TORNTPHARM.NS입니다.

지난 12개월 동안 Torrent Pharmaceuticals은(는) 28 INR 의 배당금을 지급했습니다. 이는 약 0.9 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Torrent Pharmaceuticals은(는) 29.5 INR의 배당금을 지급할 것으로 예상됩니다.

Torrent Pharmaceuticals의 현재 배당 수익률은 0.9 %입니다.

Torrent Pharmaceuticals은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Torrent Pharmaceuticals은(는) 지난 23년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 29.5 INR의 배당금이 예상됩니다. 이는 배당수익률 0.95 %에 해당합니다.

Torrent Pharmaceuticals은 '건강' 섹터에 속합니다.

Torrent Pharmaceuticals의 마지막 배당금을 6 INR만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Torrent Pharmaceuticals는 22 INR를 배당금으로 지급했습니다.

Torrent Pharmaceuticals의 배당금은 INR에 지급됩니다.